(Q36782677)

16 August 2017

Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study (English)

1 reference

16 August 2017

1 reference

cardiovascular disease

1 reference

8

Eric B Rimm

1 reference

16 August 2017

9

David S Siscovick

1 reference

16 August 2017

11

Joachim H Ix

1 reference

16 August 2017

10

Michael Shlipak

1 reference

16 August 2017

1

Majken K Jensen

1 reference

16 August 2017

2

Traci M Bartz

1 reference

16 August 2017

3

Kenneth J Mukamal

1 reference

16 August 2017

5

Jorge R Kizer

1 reference

16 August 2017

4

Luc Djoussé

1 reference

16 August 2017

7

Susan J Zieman

1 reference

16 August 2017

Russell P Tracy

6

1 reference

PMCID

3631840

16 August 2017

language of work or name

English

0 references

publication date

18 December 2012

1 reference

16 August 2017

1 reference

16 August 2017

36

1 reference

16 August 2017

5

1 reference

16 August 2017

1222-1228

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

16 August 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Plasma fetuin-A levels and the risk of type 2 diabetes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Fetuin-A and incident diabetes mellitus in older persons

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Fetuin-A induces cytokine expression and suppresses adiponectin production

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Cystatin C and the risk of death and cardiovascular events among elderly persons

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

The Cardiovascular Health Study: design and rationale

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

A questionnaire for the assessment of leisure time physical activities

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Fetuin-null mice are protected against obesity and insulin resistance associated with aging.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3631840

Assessment of cerebrovascular disease in the Cardiovascular Health Study

5 September 2018

1 reference

12 December 2020

Laboratory methods and quality assurance in the Cardiovascular Health Study

1 reference

12 December 2020

Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study

1 reference

12 December 2020

Bovine fetuin is an inhibitor of insulin receptor tyrosine kinase

1 reference

12 December 2020

Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)

1 reference

12 December 2020

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

1 reference

12 December 2020

Association of serum fetuin-A levels with mortality in dialysis patients

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC12-1591

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

PMCID

3631840